PD

Patrick Davies

Neuren Pharmaceuticals Limited | Non-Executive Director, Non-Executive Chairman
Mr Davies has held executive management roles in the Australian and New Zealand healthcare industry for over twenty five years having performed in senior roles across industry sectors including pharmacy, primary care, pharmaceutical and consumer products. During his ten year period as Chief Executive Officer of EBOS Group Limited (and previously Symbion), the enterprise value of the group achieved compound annual growth in enterprise value of +20% (from circa $450M to in excess of $3.1B). He is a director on other corporate boards and provides strategic advice to a range of healthcare businesses and investors.

Company and Roles

Company
Title
Tenure
Since
NEU
Neuren Pharmaceuticals Limited
  • Non-Executive Director
  • Non-Executive Chairman
6yrs, 9mthJul 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NEU
Neuren Pharmaceuticals Limited
14/03/25N/A264,634N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NEU
Neuren Pharmaceuticals Limited
08/10/21
Buy
14,634$2.050$30,000Participation in share purchase plan
NEU
Neuren Pharmaceuticals Limited
24/06/21
Buy
43,694$1.400$61,172On-market trade
NEU
Neuren Pharmaceuticals Limited
17/02/21
Buy
35,211$1.425$50,175On-market trade
NEU
Neuren Pharmaceuticals Limited
07/08/20
Buy
21,428$1.400$30,000Participation in share purchase plan
NEU
Neuren Pharmaceuticals Limited
28/05/20
Buy
28,655$1.770$50,719On-market trade